266 related articles for article (PubMed ID: 16931986)
1. Mechanism of cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel activation by isoflurane in a heterologous expression system.
Bienengraeber M; Warltier DC; Bosnjak ZJ; Stadnicka A
Anesthesiology; 2006 Sep; 105(3):534-40. PubMed ID: 16931986
[TBL] [Abstract][Full Text] [Related]
2. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
Fujita H; Ogura T; Tamagawa M; Uemura H; Sato T; Ishida A; Imamaki M; Kimura F; Miyazaki M; Nakaya H
Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
[TBL] [Abstract][Full Text] [Related]
3. Isoflurane activates sarcolemmal adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells: a role for protein kinase A.
Tanaka K; Kawano T; Nakamura A; Nazari H; Kawahito S; Oshita S; Takahashi A; Nakaya Y
Anesthesiology; 2007 May; 106(5):984-91. PubMed ID: 17457130
[TBL] [Abstract][Full Text] [Related]
4. Impact of in vivo preconditioning by isoflurane on adenosine triphosphate-sensitive potassium channels in the rat heart: lasting modulation of nucleotide sensitivity during early memory period.
Stadnicka A; Marinovic J; Bienengraeber M; Bosnjak ZJ
Anesthesiology; 2006 Mar; 104(3):503-10. PubMed ID: 16508398
[TBL] [Abstract][Full Text] [Related]
5. Isoflurane decreases ATP sensitivity of guinea pig cardiac sarcolemmal KATP channel at reduced intracellular pH.
Stadnicka A; Bosnjak ZJ
Anesthesiology; 2003 Feb; 98(2):396-403. PubMed ID: 12552199
[TBL] [Abstract][Full Text] [Related]
6. A functional role of the C-terminal 42 amino acids of SUR2A and SUR2B in the physiology and pharmacology of cardiovascular ATP-sensitive K(+) channels.
Yamada M; Kurachi Y
J Mol Cell Cardiol; 2005 Jul; 39(1):1-6. PubMed ID: 15978900
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels.
Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
Anesthesiology; 2004 Feb; 100(2):338-46. PubMed ID: 14739809
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system.
Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
Anesthesiology; 2004 Aug; 101(2):390-8. PubMed ID: 15277922
[TBL] [Abstract][Full Text] [Related]
9. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
[TBL] [Abstract][Full Text] [Related]
10. Syntaxin-1A inhibits cardiac KATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A.
Kang Y; Leung YM; Manning-Fox JE; Xia F; Xie H; Sheu L; Tsushima RG; Light PE; Gaisano HY
J Biol Chem; 2004 Nov; 279(45):47125-31. PubMed ID: 15339904
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
Fang K; Csanády L; Chan KW
J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of etomidate and midazolam on vascular adenosine triphosphate-sensitive potassium channels: isometric tension and patch clamp studies.
Nakamura A; Kawahito S; Kawano T; Nazari H; Takahashi A; Kitahata H; Nakaya Y; Oshita S
Anesthesiology; 2007 Mar; 106(3):515-22. PubMed ID: 17325510
[TBL] [Abstract][Full Text] [Related]
14. Wortmannin, an inhibitor of phosphatidylinositol kinases, blocks the MgATP-dependent recovery of Kir6.2/SUR2A channels.
Xie LH; Takano M; Kakei M; Okamura M; Noma A
J Physiol; 1999 Feb; 514 ( Pt 3)(Pt 3):655-65. PubMed ID: 9882737
[TBL] [Abstract][Full Text] [Related]
15. Long chain coenzyme A esters activate the pore-forming subunit (Kir6. 2) of the ATP-regulated potassium channel.
Bränström R; Leibiger IB; Leibiger B; Corkey BE; Berggren PO; Larsson O
J Biol Chem; 1998 Nov; 273(47):31395-400. PubMed ID: 9813050
[TBL] [Abstract][Full Text] [Related]
16. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K
Vedovato N; Rorsman O; Hennis K; Ashcroft FM; Proks P
J Physiol; 2018 Dec; 596(24):6205-6217. PubMed ID: 30179258
[TBL] [Abstract][Full Text] [Related]
17. Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1.
Flagg TP; Kurata HT; Masia R; Caputa G; Magnuson MA; Lefer DJ; Coetzee WA; Nichols CG
Circ Res; 2008 Dec; 103(12):1458-65. PubMed ID: 18974387
[TBL] [Abstract][Full Text] [Related]
18. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
19. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
[TBL] [Abstract][Full Text] [Related]
20. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
